TRANS.00034 Hematopoietic Stem Cell Transplantation for Diabetes Mellitus Form
Procedure is not covered
This document addresses the use of hematopoietic stem cell transplantation to reconstitute the immune system as a treatment of diabetes mellitus (DM).
Position Statement
Investigational and Not Medically Necessary:
Autologous or allogeneic (ablative and non-myeloablative) hematopoietic stem cell transplantation is considered investigational and not medically necessary as a treatment of diabetes mellitus.
Book a walkthrough
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.
Loading available demo times